Workflow
Up 152% in December, Is uniQure a Good Stock to Buy Now and Hold Through 2025?
QUREuniQure(QURE) The Motley Fool·2024-12-15 09:31

Shares of the international gene therapy developer uniQure (QURE 2.26%) have been soaring. Investors are responding to positive news regarding the Food and Drug Administration (FDA) and the company's Huntington's disease candidate.During the first 12 days of December, shares of uniQure rocketed 152% higher, and investors want to know if this stock has legs that can propel it further in 2025. Let's weigh the positive news that drove the stock through the roof against some challenges the drugmaker faces to se ...